Biotech Values

[spartex]

David, any updates on ZONA's fundamentals?

Last weeks move appears to have been driven by some institutions getting word from the company on confidence about their current drug trials per this Punk Ziegel upgrade of their target (below).

Do you have a target price on ZONA over the next year?

Thanks!


09:01 ZONA Zonagen tgt raised to $25 from $14 at Punk Ziegel (12.42 )

Punk Ziegel raises their tgt to $25 from $14 saying several recent developments diminish risks inherent to Zonagen's clinical programs that they had incorporated into their valuation of Zonagen and increase their confidence in the safety and efficacy of Proellex and Androxal as well as their respective market sizes. The firm says most importantly, following recent discussions with thought-leaders, their concerns about the potential for "endometrial hyperplasia" to be observed in patients receiving selective progesterone receptor modulators like Asoprisnil or Proellex and the associated risk of uterine cancer have largely been mitigated.